All In Biotech

Drugs by condition

Drugs approved for covid-19

Brand-name prescription drugs and biologics whose FDA label lists covid-19 as an approved use. Matched on the label phrases: "COVID-19".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

11

Still marketed, NDA or BLA

Drug classes

4

Novel drugs

5

New molecular entities and new biologics

In development

19

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for covid-19.

  • Xocova (Ensitrelvir) · Shionogi NovelMay 29, 2026
  • Avtozma (Tocilizumab-Anoh) · Celltrion INC Jan 21, 2026
  • Tyenne (Tocilizumab-Aazg) · Fresenius Kabi USA Mar 14, 2025
  • Avtozma (Tocilizumab-Anoh) · Celltrion INC Jan 24, 2025
  • Tyenne (Tocilizumab-Aazg) · Fresenius Kabi USA OrphanMar 5, 2024

All approved drugs for covid-19, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 0 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Interleukin-6 Receptor Antagonist (7)

  • Actemra Tocilizumab · Genentech · 2010
  • Avtozma Tocilizumab-Anoh · Celltrion INC · 2026
  • Tyenne Tocilizumab-Aazg · Fresenius Kabi USA · 2025
  • Avtozma Tocilizumab-Anoh · Celltrion INC · 2025
  • Tyenne Tocilizumab-Aazg · Fresenius Kabi USA · 2024
  • Tofidence Tocilizumab-Bavi · Biogen Ma · 2023
  • Actemra Tocilizumab · Genentech · 2013

SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor (1)

  • Veklury Remdesivir · Gilead Sciences INC · 2020

Janus Kinase Inhibitor (1)

  • Olumiant Baricitinib · Eli Lilly and CO · 2018

Class not listed in FDA's data (2)

Drugs in development for covid-19

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • BioNTech SE · Influenza, COVID-19, COVID-19 (Coronavirus Disease 2019)

  • ibuzatrelvirPF-07817883Phase 32 trials

    Pfizer · COVID-19 SARS-CoV-2 Infection, COVID-19 Infection

  • IIV-HDstandalonePhase 32 trials

    Sanofi · COVID-19 Immunization, Influenza Immunization, Immunization

  • RVX000222apabetalone, RVX-208Phase 32 trials

    Resverlogix Corp · Post-Acute COVID-19 Syndrome, Kidney Failure, Chronic

  • VYD2311Phase 32 trials

    Invivyd, Inc. · Long COVID, COVID-19 (SARS-CoV-2 Infection), COVID 19 Vaccine

  • DAS181Phase 31 trial

    Ansun Biopharma, Inc. · Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised

  • MolnupiravirMK-4482, LAGEVRIOPhase 31 trial

    Merck & Co. · Coronavirus Disease (COVID-19)

  • NVXC19EU licensed, standalonePhase 31 trial

    Sanofi · Immunization, Healthy Volunteers, COVID-19 Immunization

  • SCTA01Phase 31 trial

    Sinocelltech Ltd. · COVID-19, SARS-CoV-2

  • VYD222pemivibartPhase 31 trial

    Invivyd, Inc. · COVID-19, SARS-CoV-2

  • VYD2311-MDPhase 31 trial

    Invivyd, Inc. · COVID-19

  • VYD2311-SDPhase 31 trial

    Invivyd, Inc. · COVID-19

  • RimonabantPhase 24 trials

    Sinfatin S.L · Chronic Stroke, Subacute Stroke, Post-COVID-19 Syndrome

  • Ever Supreme Bio Technology Co., Ltd. · COVID-19 Infection, Multiple Sclerosis, ST Elevation Myocardial Infarction

  • COH04S1GEO-CM04S1, Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1Phase 22 trials

    GeoVax, Inc. · COVID-19 Infection, Hematopoietic and Lymphoid System Neoplasm, Leukemia

  • CVXGACVXGA50, PIV5-SARS CoV-2Phase 22 trials

    CyanVac LLC · COVID-19

  • rC19Novavax's adjuvanted recombinant COVID-19Phase 22 trials

    Sanofi · COVID-19 Immunization, Influenza Immunization

  • AV-001Phase 21 trial

    Vasomune Therapeutics, Inc. · Acute Respiratory Distress Syndrome, Viral or Bacterial Infections, Pneumonia

  • GC4006APhase 21 trial

    GC Biopharma Corp · Covid-19 Prevention

More on covid-19: recruiting trials · published research

Related in infectious disease and vaccines: HIV · Hepatitis B · Hepatitis C · Influenza · RSV · Urinary tract infection · Pneumonia · Skin infections · C. difficile infection · Fungal infections

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.